Inhibit the HIF1α/SDF1α-CXCR4/PI3K-AKT signaling pathway to reduce vascular endothelial growth factor synthesis and release, decrease type IV collagen degradation, and suppress tumor growth and liver metastasis in nude mice. Here, CXCL12 is linked to neoplasm.